China Kanghui Holdings Announces Pricing of Initial Public Offering
Changzhou, China - August 10, 2010

FDA Approves Sagent Pharmaceuticals, Inc.'s Heparin Sodium Injection, USP
Schaumburg, IL - July 1, 2010

Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders
Malvern, PA – June 30, 2010

Dynavax Raises $44 Million Through Public Offering of Common Stock and Warrants
Berkeley, CA - April 13, 2010

Sagent Pharmaceuticals Raises $40 Million in Two Tranches of a Series B Financing
Schaumburg, IL - April 8, 2010

Merz to Acquire BioForm Medical
Frankfurt, Germany & San Mateo, CA - January 4, 2010

Lee's Pharmaceutical Signed a Subscription Agreement with Vivo Ventures Fund
Shatin, Hong Kong - August 12, 2009

AVANIR Announces Positive Phase III Study Results for Zenvia
Aliso Viejo, CA - August 11, 2009

Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
Palo Alto, CA - August 10, 2009

KangHui Medical Raises Series B-1 Extension Round
Palo Alto, CA - April 24, 2009

Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Palo Alto, CA - February 24, 2009

APT Pharmaceuticals Secures $32 Million in Series B Financing
Burlingame, CA - September 30, 2008

Sagent Completes $30 Million Series A Financing Extension
Schaumburg, IL - September 4, 2008

SpectraGenics Announces $30M in New Funding Changes Company Name to Tria Beauty
Pleasanton, CA - July 10, 2008

AVANIR to Raise $40.0 Million to Fund Zenvia Through Clinical Development and Regulatory Approval
Palo Alto, CA - Nov 26, 2007

Carbylan Announces $20 Million Series B Financing
Aliso Viejo, CA - March 27, 2008

Yaupon Therapeutics closes $14.5 million financing -- Series C financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases
Radnor, PA - Nov 26, 2007

BioForm Announces Pricing of Initial Public Offering
San Mateo, CA - Nov 07, 2007

Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
Palo Alto, CA ? October 24, 2007 ? Vivo Ventures

APT Pharmaceuticals Closes New $22 Million Funding Round
Burlingame, CA - October 4, 2007

Sagent Pharmaceuticals Inc. Completes $53M Series A Financing
Schaumburg, IL - September 27, 2007

Acura Pharmaceuticals, Inc. secures financing to fund pivotal Phase III clinical trial for lead Aversion® technology product candidate
Palatine, IL - August 20, 2007

Capnia names chairman, CEO
Palo Alto, CA - August 6, 2007

Biodel Inc. Announces Completion of Public Offering
DANBURY, CT - May 17, 2007

Vivo Ventures Announces the Closing of Vivo Ventures Fund VI, a $275M Life Science Venture Fund
Palo Alto, CA - May 7, 2007

At Vivo Ventures, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors.  Vivo prides itself on its working relationships with its founders who have often continued to work with the firm in other startup ventures.  The majority of Vivo's investments are in U.S. based companies with therapeutic products in clinical development. . . MORE